Vimedimex Medi-Pharma JSC (HOSE:VMD)
Vietnam flag Vietnam · Delayed Price · Currency is VND
12,400
0.00 (0.00%)
At close: Nov 3, 2026

Vimedimex Medi-Pharma JSC Balance Sheet

Millions VND. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Dec '23 Jan '23 Dec '21
Cash & Equivalents
82,054128,642301,122209,806213,681148,753
Short-Term Investments
314,956224,90033,96039,64942,69531,158
Cash & Short-Term Investments
397,010353,542335,082249,455256,375179,911
Cash Growth
12.29%5.51%34.33%-2.70%42.50%-46.13%
Accounts Receivable
-20,343307,165646,4171,141,6412,000,498
Other Receivables
33,69362,651199,624406,871163,986163,544
Receivables
33,69382,994506,7901,053,2881,305,6262,164,042
Inventory
6,25719,47584,864247,076947,1322,531,669
Prepaid Expenses
--1,7061,6174,1752,896
Other Current Assets
732.89-47,86162,826299,011401,119
Total Current Assets
437,693456,011976,3031,614,2622,812,3205,279,637
Property, Plant & Equipment
42,43444,500110,781134,506132,700146,847
Long-Term Investments
7,9317,9318,9917,9317,9316,551
Other Intangible Assets
14,81215,16131,82717,31318,16818,818
Long-Term Deferred Tax Assets
-----94.93
Other Long-Term Assets
871,4621,648,64469,55276,28482,40279,558
Total Assets
1,374,3662,172,2471,197,4551,850,2963,053,5225,531,506

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Dec '23 Jan '23 Dec '21
Accounts Payable
4,518159,884598,3831,063,5061,908,6994,183,257
Accrued Expenses
9,064-20,1479,79717,043221,264
Short-Term Debt
-----612,374
Current Income Taxes Payable
-8,9345,9313,4895,880-
Current Unearned Revenue
---224.02151.5-
Other Current Liabilities
5,416108,270137,870332,149682,30194,179
Total Current Liabilities
18,998277,089762,3311,409,1652,614,0735,111,074
Other Long-Term Liabilities
762,6101,362,12718,47020,07720,74623,664
Total Liabilities
781,6081,639,216780,8001,429,2422,634,8195,134,738

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Dec '23 Jan '23 Dec '21
Common Stock
154,403154,403154,403154,403154,403154,403
Additional Paid-In Capital
114,168114,168114,168114,168114,168114,168
Retained Earnings
147,34498,59659,41864,34871,62353,266
Comprehensive Income & Other
7,3387,3389,2629,2629,2628,206
Total Common Equity
423,254374,506337,251342,181349,456330,042
Minority Interest
169,504158,52579,40478,87369,24666,726
Shareholders' Equity
592,758533,031416,654421,054418,702396,768
Total Liabilities & Equity
1,374,3662,172,2471,197,4551,850,2963,053,5225,531,506

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Dec '23 Jan '23 Dec '21
Total Debt
-----612,374
Net Cash (Debt)
397,010353,542335,082249,455256,375-432,463
Net Cash Growth
12.29%5.51%34.33%-2.70%--
Net Cash Per Share
25711.3322897.4321701.8316152.3216604.34-28008.76
Filing Date Shares Outstanding
15.4415.4415.4415.4415.4415.44
Total Common Shares Outstanding
15.4415.4415.4415.4415.4415.44
Working Capital
418,695178,922213,972205,097198,247168,563
Book Value Per Share
27406.7624255.1421842.2822161.6022633.9121375.44
Tangible Book Value
408,442359,345305,423324,868331,288311,224
Tangible Book Value Per Share
26447.6423273.2519780.9621040.3221457.1820156.64
Buildings
-23,37678,94177,89677,89679,708
Machinery
-25,843120,033120,033108,504108,463
Construction In Progress
32,24232,24233,90546,97241,38540,563